A group of 35 beauty manufacturers, suppliers, industry associations and animal welfare groups have established a global collective to advance animal-free safety assessments in cosmetics worldwide.
Unilever-owned international beauty brand Dove is making a final push to inspire more European consumers to align on protecting the EU’s ban on animal testing in cosmetics.
The publication of defined approaches to in silico skin sensitisation chemical assessment is a landmark moment for the Organisation for Economic Co-operation and Development (OECD) with significant implications for an animal-free future, say agency leaders.
Members of the European Parliament (MEPs) have adopted a resolution vote calling on the European Commission to establish an EU-wide action plan to actively phase out animal experiments – a move that adds weight to the cosmetics industry’s fight to protect...
The Body Shop and Dove combining their scale and size brings a collective power to push forward calls to protect the EU’s existing animal testing ban on cosmetics, company executives say.
The move by France to provide a government platform enabling beauty manufacturers to qualify for exemptions when exporting general-use cosmetics to China should carve out a path for other countries to follow, says a Procter & Gamble executive.
The list of countries with animal testing bans in place for cosmetics is growing, but how close is industry to reaching the EU Parliament’s goal of a blanket global ban by 2023?
The cosmetics industry has heavily invested in advancing non-animal safety testing methods, now efforts must turn to driving regulatory acceptance of these next-generation alternatives, says the founder of animal-free testing lab XCellR8.
Procter & Gamble, Unilever, L’Oréal and Avon are among signatories of an open statement claiming the European Chemicals Agency (ECHA) and its Board of Appeal is undermining the EU animal testing ban on cosmetics - a claim the agency refutes.
Animal testing for scientific purposes across the European Union has declined in recent years and cosmetics is in a strong position to share advances made with in-vitro alternatives, says UK medical research charity FRAME.
L'Oréal has been granted a license by authorities in China for its Episkin Biotechnology business, giving it the right to market its reconstructed skin model in the country.
Animal testing alternatives, regulatory issues and innovation
within the industry are amongst the subjects on the agenda at
Colipa's annual general assembly next month.